drugset
drugset / Trial / NCT05663125

LITT Combined With Early Use of Temozolomide for Recurrent Glioblastomas

NCT05663125 ↗

Phase 1/2 Unknown 10 enrolled Beijing Tiantan Hospital
NaSingle-groupOpen-labelTreatment

Summary

This study aims to investigate the safety and efficacy of Laser Interstitial Thermal Therapy (LITT) combined with postoperative early use of temozolomide in treating recurrent glioblastomas.

Timeline

Start
2022-12-01
Primary completion
2023-12-01
Completion
2024-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Temozolomide Small molecule 75 mg/m2 Oral

Indications

glioblastoma